Last reviewed · How we verify
V565
At a glance
| Generic name | V565 |
|---|---|
| Sponsor | VHsquared Ltd. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Six Week Efficacy, Safety and Tolerability Study of V565 in Crohn's Disease (PHASE2)
- Open-label V565 Target Engagement Study (PHASE1)
- A First Time in Human Study in Healthy Volunteers and Patients (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- V565 CI brief — competitive landscape report
- V565 updates RSS · CI watch RSS
- VHsquared Ltd. portfolio CI